1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:

3.2.2 Macroeconomic factor analysis:

3.2.3 Developing base number:

3.2.4 Data Triangulation:

3.2.5 Country-level data:

4. Europe Biologics Market - Key Market Dynamics

4.1 Market Drivers

4.1.1 Increasing Prevalence of Chronic Diseases

4.1.2 Preference for Outsourcing Manufacturing Operations

4.2 Market Restraints

4.2.1 High Cost of Biologics

4.3 Market Opportunities

4.3.1 Gene and Cell Therapy Advancements in Biologics

4.4 Future Trends

4.4.1 Strategic Initiatives by Companies

4.5 Impact of Drivers and Restraints:

5. Biologics Market - Europe Analysis

5.1 Europe Biologics Market Revenue (US$ Million), 2021-2031

5.2 Europe Biologics Market Forecast Analysis

6. Europe Biologics Market Analysis - by Product

6.1 Monoclonal Antibodies

6.1.1 Overview

6.1.2 Monoclonal Antibodies: Europe Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

6.2 Vaccine

6.2.1 Overview

6.2.2 Vaccine: Europe Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

6.3 Recombinant Hormones/Proteins

6.3.1 Overview

6.3.2 Recombinant Hormones/Proteins: Europe Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

6.4 Cell and Gene Therapy

6.4.1 Overview

6.4.2 Cell and Gene Therapy: Europe Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

6.5 Others

6.5.1 Overview

6.5.2 Others: Europe Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

7. Europe Biologics Market Analysis - by Application

7.1 Cancer

7.1.1 Overview

7.1.2 Cancer: Europe Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

7.2 Infectious Diseases

7.2.1 Overview

7.2.2 Infectious Diseases: Europe Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

7.3 Autoimmune Diseases

7.3.1 Overview

7.3.2 Autoimmune Diseases: Europe Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

7.4 Others

7.4.1 Overview

7.4.2 Others: Europe Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Europe Biologics Market Analysis - by Source

8.1 Mammalian

8.1.1 Overview

8.1.2 Mammalian: Europe Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

8.2 Microbial

8.2.1 Overview

8.2.2 Microbial: Europe Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Europe Biologics Market Analysis - by Manufacturing

9.1 Outsourced

9.1.1 Overview

9.1.2 Outsourced: Europe Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

9.2 In-house

9.2.1 Overview

9.2.2 In-house: Europe Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. Europe Biologics Market - Country Analysis

10.1 Europe

10.1.1 Europe Biologics Market - Revenue and Forecast Analysis - by Country

10.1.1.1 Europe Biologics Market - Revenue and Forecast Analysis - by Country

10.1.1.2 Germany: Europe Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

10.1.1.2.1 Germany: Europe Biologics Market Share - by Product

10.1.1.2.2 Germany: Europe Biologics Market Share - by Application

10.1.1.2.3 Germany: Europe Biologics Market Share - by Source

10.1.1.2.4 Germany: Europe Biologics Market Share - by Manufacturing

10.1.1.3 United Kingdom: Europe Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

10.1.1.3.1 United Kingdom: Europe Biologics Market Share - by Product

10.1.1.3.2 United Kingdom: Europe Biologics Market Share - by Application

10.1.1.3.3 United Kingdom: Europe Biologics Market Share - by Source

10.1.1.3.4 United Kingdom: Europe Biologics Market Share - by Manufacturing

10.1.1.4 Italy: Europe Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

10.1.1.4.1 Italy: Europe Biologics Market Share - by Product

10.1.1.4.2 Italy: Europe Biologics Market Share - by Application

10.1.1.4.3 Italy: Europe Biologics Market Share - by Source

10.1.1.4.4 Italy: Europe Biologics Market Share - by Manufacturing

10.1.1.5 France: Europe Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

10.1.1.5.1 France: Europe Biologics Market Share - by Product

10.1.1.5.2 France: Europe Biologics Market Share - by Application

10.1.1.5.3 France: Europe Biologics Market Share - by Source

10.1.1.5.4 France: Europe Biologics Market Share - by Manufacturing

10.1.1.6 Spain: Europe Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

10.1.1.6.1 Spain: Europe Biologics Market Share - by Product

10.1.1.6.2 Spain: Europe Biologics Market Share - by Application

10.1.1.6.3 Spain: Europe Biologics Market Share - by Source

10.1.1.6.4 Spain: Europe Biologics Market Share - by Manufacturing

10.1.1.7 Rest of Europe: Europe Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

10.1.1.7.1 Rest of Europe: Europe Biologics Market Share - by Product

10.1.1.7.2 Rest of Europe: Europe Biologics Market Share - by Application

10.1.1.7.3 Rest of Europe: Europe Biologics Market Share - by Source

10.1.1.7.4 Rest of Europe: Europe Biologics Market Share - by Manufacturing

11. Industry Landscape

11.1 Overview

11.2 Market Initiative

11.3 Partnerships and Collaborations

11.4 Other Developments

12. Company Profiles

12.1 AbbVie Inc

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Pfizer Inc

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Samsung Biologics Co Ltd

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 ADMA Biologics, Inc.

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 WuXi Biologics Inc

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Catalent Inc

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 AGC Biologics AS

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 AstraZeneca Plc

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Amgen Inc

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Nitto Avecia

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

12.11 Quality Assistance s.a.

12.11.1 Key Facts

12.11.2 Business Description

12.11.3 Products and Services

12.11.4 Financial Overview

12.11.5 SWOT Analysis

12.11.6 Key Developments

13. Appendix

13.1 About Us

List of Tables

Table 1. Europe Biologics Market Segmentation

Table 2. Europe Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Table 3. Europe Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Product

Table 4. Europe Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Application

Table 5. Europe Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Source

Table 6. Europe Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Manufacturing

Table 7. Europe Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country

Table 8. Germany: Europe Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product

Table 9. Germany: Europe Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application

Table 10. Germany: Europe Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source

Table 11. Germany: Europe Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Manufacturing

Table 12. United Kingdom: Europe Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product

Table 13. United Kingdom: Europe Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application

Table 14. United Kingdom: Europe Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source

Table 15. United Kingdom: Europe Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Manufacturing

Table 16. Italy: Europe Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product

Table 17. Italy: Europe Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application

Table 18. Italy: Europe Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source

Table 19. Italy: Europe Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Manufacturing

Table 20. France: Europe Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product

Table 21. France: Europe Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application

Table 22. France: Europe Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source

Table 23. France: Europe Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Manufacturing

Table 24. Spain: Europe Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product

Table 25. Spain: Europe Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application

Table 26. Spain: Europe Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source

Table 27. Spain: Europe Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Manufacturing

Table 28. Rest of Europe: Europe Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product

Table 29. Rest of Europe: Europe Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application

Table 30. Rest of Europe: Europe Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source

Table 31. Rest of Europe: Europe Biologics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Manufacturing

List of Figures

Figure 1. Europe Biologics Market Segmentation - Country

Figure 2. Europe Biologics Market - Key Market Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Europe Biologics Market Revenue (US$ Million), 2021-2031

Figure 5. Europe Biologics Market Share (%) - by Product (2023 and 2031)

Figure 6. Monoclonal Antibodies: Europe Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 7. Vaccine: Europe Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 8. Recombinant Hormones/Proteins: Europe Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 9. Cell and Gene Therapy: Europe Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 10. Others: Europe Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 11. Europe Biologics Market Share (%) - by Application (2023 and 2031)

Figure 12. Cancer: Europe Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 13. Infectious Diseases: Europe Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 14. Autoimmune Diseases: Europe Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 15. Others: Europe Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 16. Europe Biologics Market Share (%) - by Source (2023 and 2031)

Figure 17. Mammalian: Europe Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 18. Microbial: Europe Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 19. Europe Biologics Market Share (%) - by Manufacturing (2023 and 2031)

Figure 20. Outsourced: Europe Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 21. In-house: Europe Biologics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 22. Europe Biologics Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 23. Germany: Europe Biologics Market - Revenue and Forecast, 2021- 2031 (US$ Million)

Figure 24. United Kingdom: Europe Biologics Market - Revenue and Forecast, 2021- 2031 (US$ Million)

Figure 25. Italy: Europe Biologics Market - Revenue and Forecast, 2021- 2031 (US$ Million)

Figure 26. France: Europe Biologics Market - Revenue and Forecast, 2021- 2031 (US$ Million)

Figure 27. Spain: Europe Biologics Market - Revenue and Forecast, 2021- 2031 (US$ Million)

Figure 28. Rest of Europe: Europe Biologics Market - Revenue and Forecast, 2021- 2031 (US$ Million)